By Dr William Brooks

Preprints

Bateman RJ; Li Y; McDade EM; Llibre-Guerra JJ; Clifford DB; Atri A; Mills SL; Santacruz AM; Wang G; Supnet C; Benzinger TLS; Gordon BA; Ibanez L; Klein G; Baudler M; Doody RS; Delmar P; Kerchner GA; Bittner T; Wojtowicz J; Bonni A; Fontoura P; Hofmann C; Kulic L; Hassenstab J; Aschenbrenner AJ; Perrin RJ; Cruchaga C; Renton AE; Xiong C; Goate AA; Morris JC; Holtzman DM; Snider BJ; Mummery C; Brooks WS; Wallon D; Berman SB; Roberson E; Masters CL; Galasko DR; Jayadev S; Sanchez-Valle R; Pariente J; Kinsella J; van Dyck CH; Gauthier S; Robin Hsiung G-Y; Masellis M; Dubois B; Honig LS; Jack CR; Daniels A; Aguillón D; Allegri R; Chhatwal J; Day G; Fox N; Huey E; Ikeuchi T; Jucker M; Lee J-H; Levey AI; Levin J; Lopera F; Roh J; Rosa-Neto P; Schofield PR; Dominantly Inherited Alzheimer’s Disease-Trials Unit , 2025, Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial., http://dx.doi.org/10.1101/2024.10.29.24316289

McKay NS; Gordon BA; Hornbeck RC; Jack CR; Koeppe R; Flores S; Keefe S; Hobbs DA; Joseph-Mathurin N; Wang Q; Rahmani F; Chen CD; McCullough A; Koudelis D; Chua J; Ances BM; Millar PR; Nickels M; Perrin RJ; Allegri RF; Berman SB; Brooks WS; Cash DM; Chhatwal JP; Farlow MR; Fox NC; Fulham M; Ghetti B; Graff-Radford N; Ikeuchi T; Day G; Klunk W; Levin J; Lee J-H; Martins R; Masters CL; McConathy J; Mori H; Noble JM; Rowe C; Salloway S; Sanchez-Valle R; Schofield PR; Shimada H; Shoji M; Su Y; Suzuki K; Vöglein J; Yakushev I; Swisher L; Cruchaga C; Hassenstab J; Karch C; McDade E; Xiong C; Morris JC; Bateman RJ; Benzinger TLS, 2022, Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRI, http://dx.doi.org/10.1101/2022.03.25.485799

Back to profile page